These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35417737)

  • 41. Re: COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London. A reply.
    Adam EJ; Grubnic S; Jacob TM; Patel JH; Blanks R
    Clin Radiol; 2021 Jun; 76(6):468-469. PubMed ID: 33832702
    [No Abstract]   [Full Text] [Related]  

  • 42. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
    Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN
    Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England.
    Saatci D; Ranger TA; Garriga C; Clift AK; Zaccardi F; Tan PS; Patone M; Coupland C; Harnden A; Griffin SJ; Khunti K; Dambha-Miller H; Hippisley-Cox J
    JAMA Pediatr; 2021 Sep; 175(9):928-938. PubMed ID: 34152371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
    Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital.
    Martyn EM; Whitaker H; Gil E; Ighomereho P; Lambe G; Conley R; Saldiray J; Ladhani SN; Mirfenderesky M
    J Infect; 2021 Jun; 82(6):276-316. PubMed ID: 33676961
    [No Abstract]   [Full Text] [Related]  

  • 46. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
    Meredith LW; Hamilton WL; Warne B; Houldcroft CJ; Hosmillo M; Jahun AS; Curran MD; Parmar S; Caller LG; Caddy SL; Khokhar FA; Yakovleva A; Hall G; Feltwell T; Forrest S; Sridhar S; Weekes MP; Baker S; Brown N; Moore E; Popay A; Roddick I; Reacher M; Gouliouris T; Peacock SJ; Dougan G; Török ME; Goodfellow I
    Lancet Infect Dis; 2020 Nov; 20(11):1263-1272. PubMed ID: 32679081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London.
    Snell LB; Wang W; Alcolea-Medina A; Charalampous T; Batra R; de Jongh L; Higgins F; Nebbia G; ; Wang Y; Edgeworth J; Curcin V
    BMJ Open; 2022 Feb; 12(2):e055474. PubMed ID: 35135773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
    Elliott P; Bodinier B; Eales O; Wang H; Haw D; Elliott J; Whitaker M; Jonnerby J; Tang D; Walters CE; Atchison C; Diggle PJ; Page AJ; Trotter AJ; Ashby D; Barclay W; Taylor G; Ward H; Darzi A; Cooke GS; Chadeau-Hyam M; Donnelly CA
    Science; 2022 Mar; 375(6587):1406-1411. PubMed ID: 35133177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England.
    Brooks-Pollock E; Northstone K; Pellis L; Scarabel F; Thomas A; Nixon E; Matthews DA; Bowyer V; Garcia MP; Steves CJ; Timpson NJ; Danon L
    BMC Med; 2023 Jan; 21(1):25. PubMed ID: 36658548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
    Bramley A; Crocker-Buque T; Breuer J; Mahungu TW
    J Infect; 2021 Oct; 83(4):496-522. PubMed ID: 34419558
    [No Abstract]   [Full Text] [Related]  

  • 52. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project.
    Hedberg P; Varisco B; Bai F; Sönnerborg A; Naucler P; Pfeifer N; Cozzi-Lepri A; Ceccherini-Silberstein F; Naumovas D; Drobniewski F; Jensen BO; Toscano C; Parczewski M; Quintanares GHR; Mwau M; Pinto JA; Incardona F; Mommo C; Marchetti G
    BMC Infect Dis; 2023 Oct; 23(1):690. PubMed ID: 37845624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England.
    Vusirikala A; Whitaker H; Jones S; Tessier E; Borrow R; Linley E; Hoschler K; Baawuah F; Ahmad S; Andrews N; Ramsay M; Ladhani SN; Brown KE; Amirthalingam G
    J Infect; 2021 Jul; 83(1):104-111. PubMed ID: 33933527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year.
    Smith C; Odd D; Harwood R; Ward J; Linney M; Clark M; Hargreaves D; Ladhani SN; Draper E; Davis PJ; Kenny SE; Whittaker E; Luyt K; Viner R; Fraser LK
    Nat Med; 2022 Jan; 28(1):185-192. PubMed ID: 34764489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people.
    Brookman S; Cook J; Zucherman M; Broughton S; Harman K; Gupta A
    Lancet Child Adolesc Health; 2021 Apr; 5(4):e9-e10. PubMed ID: 33581054
    [No Abstract]   [Full Text] [Related]  

  • 57. The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi-centre study of the first COVID-19 wave.
    McGlacken-Byrne SM; Drew SEV; Turner K; Peters C; Amin R
    Diabet Med; 2021 Sep; 38(9):e14640. PubMed ID: 34245598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era.
    Barnard RC; Davies NG; ; Jit M; Edmunds WJ
    Nat Commun; 2022 Aug; 13(1):4879. PubMed ID: 35986002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study.
    Goodall JW; Reed TAN; Ardissino M; Bassett P; Whittington AM; Cohen DL; Vaid N
    Epidemiol Infect; 2020 Oct; 148():e251. PubMed ID: 33046155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study.
    Hippisley-Cox J; Khunti K; Sheikh A; Nguyen-Van-Tam JS; Coupland CAC
    BMJ; 2023 Jun; 381():e072976. PubMed ID: 37343968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.